PMD9 A Comparative Assessment of Cost Implications of Novel Drug Versus Novel Device-Based Treatments for Stroke Prevention in Atrial Fibrillation
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.858
https://www.valueinhealthjournal.com/article/S1098-3015(12)02571-5/fulltext
Section Title :
Medical Device/Diagnostics
Section Order :
366
First Page :
A346
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02571-5&doi=10.1016/j.jval.2012.08.858